{
  "paper_id": "PMC12383716",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12383716/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "Remote ischaemic preconditioning (RIPC) and control group (CG) protocols.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/7059a6378b36/biomedicines-13-01923-g001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/7059a6378b36/biomedicines-13-01923-g001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/7059a6378b36/biomedicines-13-01923-g001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/7059a6378b36/biomedicines-13-01923-g001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "biomedicines-13-01923-f001",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/7059a6378b36/biomedicines-13-01923-g001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC12383716/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/7059a6378b36/biomedicines-13-01923-g001.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.",
      "caption": "Flowchart for patient inclusion and follow-up: screening, inclusion and exclusion, randomisation, baseline testing, and postintervention testing.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/ef3a0c2e4c58/biomedicines-13-01923-g002.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/ef3a0c2e4c58/biomedicines-13-01923-g002.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/ef3a0c2e4c58/biomedicines-13-01923-g002.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/ef3a0c2e4c58/biomedicines-13-01923-g002.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "biomedicines-13-01923-f002",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/ef3a0c2e4c58/biomedicines-13-01923-g002.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC12383716/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab93/12383716/ef3a0c2e4c58/biomedicines-13-01923-g002.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Randomisation\nParticipants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Participants will be randomly assigned (1:1) via EPIDAT version 4.2 software (Figure 1) to one of two groups: Group 1, RIPC; Group 2, the control group (CG).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2 presents the flowchart detailing patient inclusion and follow-up steps, including screening, eligibility criteria, randomisation, baseline assessments, and evaluations after the intervention.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 2,
    "claims_count": 23,
    "images_downloaded": 2,
    "tables_filtered": 228
  }
}